CYP46A1 and brain disorder: This study describes the molecular mechanisms by which CYP46A1 modulates neuronal outgrowth and function, highlighting the cholesterol 24-hydroxylase as an attractive drug target in the physiological and pathological context of cognitive decline and brain disorders.